Sign In
Buy KVUE
$16.83
-0.490 (-2.83%)
At Close: Jun 03, 2026
4 Strong Buy Dividend Aristocrats Wall Street Loves Are Trading Just Above 52-Week Lows
08:32am, Thursday, 09'th May 2024
Want retirement to come a few years earlier than you'd planned? Orare you ready to retire now, but want an extra set of eyes on your finances?
4 Dividend Aristocrats To Buy In May Plus 4 To Watch
12:04pm, Wednesday, 08'th May 2024
4 Dividend Aristocrats To Buy In May Plus 4 To Watch
Kenvue shares rise on first quarter earnings beat
10:46am, Tuesday, 07'th May 2024
Kenvue Inc (NYSE:KVUE) shares moved higher after the Tylenol-maker posted better-than-expected first quarter earnings on Tuesday. Shares of the Johnson & Johnson (NYSE:JNJ) consumer healthcare spin-of
Kenvue's stock jumps 4.7% after earnings beat and news company to cut 4% of global workforce
06:53am, Tuesday, 07'th May 2024
Kenvue Inc.'s stock KVUE, -0.63% jumped 4.7% early Tuesday, after the consumer health business that was spun out of Johnson & Johnson last year posted better-than-expected first-quarter earnings and a
Tylenol maker Kenvue beats quarterly profit estimates, to cut 4% jobs
06:47am, Tuesday, 07'th May 2024
Kenvue beat Wall Street estimates for first-quarter profit on Tuesday, and said it would cut 4% of its global workforce amid the Tylenol and Band-Aid maker's efforts to expand its key brands.
Kenvue Reports First Quarter 2024 Results
06:45am, Tuesday, 07'th May 2024
SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) (“Kenvue”), today announced financial results for the fiscal first quarter ended March 31, 2024. “We entered 2024 with clear strategic p
Investor Alert: Are These 3 Spinoff Stocks Destined to Sizzle or Fizzle?
06:58am, Monday, 06'th May 2024
There's a lot of evidence suggesting that spinoff stocks are generally a good idea to watch. Following a split from their parent company, many such firms do well thanks to their efficiency and newly-f
7 Dividend Aristocrats Paying Sky-High Yields: April 2024
04:30pm, Tuesday, 30'th Apr 2024
Few investment strategies have performed as well for as long as dividend investing. Numerous studies show that buying stocks that have initiated a dividend and then increased it over time beat all oth
7 Stocks to Buy if Inflation Continues to Reign in 2024
06:38am, Saturday, 27'th Apr 2024
Before considering which stocks to buy if inflation continues, it's good to remember the relationship between inflation and interest rates. The latest reading on CPI and PPI shows that the declining
Steady Eddies: 7 Rock-Solid Stocks to Anchor Your Portfolio in April
06:00am, Friday, 26'th Apr 2024
Perhaps the biggest justification for steady stocks comes from an asset class completely unrelated to the equities market: cryptocurrencies. After the benchmark blockchain asset hit a record high earl
Here Are My Top 5 Dividend Kings to Buy Right Now
09:15am, Thursday, 25'th Apr 2024
Dividend income can be a good way to bolster growth in your portfolio's value. Dividend Kings are companies that have paid and raised their dividend for at least 50 years.
Kenvue Declares Quarterly Cash Dividend
06:55am, Thursday, 25'th Apr 2024
SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue today announced a dividend payable in Q2 of $0.20 per share on the Company's common stock. The dividend is payable on May 22, 2024.
3 Dividend Kings Down 11% You'll Regret Not Buying on the Dip
08:00am, Monday, 22'nd Apr 2024
Dividend stocks have a proven record of stock market outperformance. For nearly 100 years, income-generating stocks on the S&P 500 have beaten non-payers.
Court Orders Johnson & Johnson And Kenvue To Pay $45 Million In Talcum Baby Powder Lawsuit
03:25pm, Saturday, 20'th Apr 2024
An Illinois court late Friday ordered pharmaceutical giant Johnson & Johnson and Kenvue to pay $45 million to a family that alleged the companies' talcum-based baby powder led to the death of a relati
Invest Like a Hawk: 7 Stocks to Own If the Fed Stays Tough
12:55pm, Wednesday, 17'th Apr 2024
While earlier discussions focused on the Federal Reserve's potential interest rate cuts, that's no longer a surefire proposition, thus warranting consideration for stocks for Fed hikes. Let's break th
